Aimmune Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Get Alerts AIMT Hot Sheet
Join SI Premium – FREE
— Presentation on September 18, 2015, at 9:45 a.m. GMT —
BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, today announced that it will present at the Bank of America Merrill Lynch Global Healthcare Conference in London.
About the Presentation
- Friday, September 18, 2015, at 9:45 a.m. GMT
- The live audio webcast of the presentation can be accessed from the Investor Relations section of the company’s website at www.aimmune.com.
- A replay will be available for 14 days following the presentation.
About Aimmune Therapeutics
Aimmune Therapeutics, Inc., founded in 2011 as Allergen Research Corporation (ARC), is a clinical-stage biopharmaceutical company developing treatments for peanut allergy and other food allergies. Aimmune Therapeutics’ characterized oral desensitization immunotherapy (CODIT™) system, an approach to oral immunotherapy (OIT), uses rigorously characterized product candidates with gradual, controlled up-dosing protocols to obtain clinically meaningful desensitization to food allergens. Aimmune Therapeutics recently completed a Phase 2 study of its lead product, AR101, a complex mixture of naturally occurring proteins and pharmaceutical-grade ingredients for the treatment of peanut allergy, one of the most common food allergies. For more information, please see www.aimmune.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150902006252/en/
Aimmune Therapeutics, Inc.
Amy Figueroa, 650-352-1039 (Investors)
[email protected]
or
Edelman
Amanda
Breeding, 415-229-7649 (Media)
[email protected]
Source: Aimmune Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FirstEnergy Corp. (FE) PT Raised to $35 at BofA Securities
- Premier Cloud Announces the Promotion of Adel Ben Rzouga to Chief Technology Officer
- SIC Wafer Polishing Market to Reach USD 6.64 Billion by 2031 Driven by Soaring Demand in Power Electronics and Automotive Sectors
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!